Drug Profile
Lassa fever vaccine
Latest Information Update: 23 Apr 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Lassa fever
Most Recent Events
- 16 Mar 2000 New profile
- 16 Mar 2000 Preclinical development for Lassa fever in USA (PO)